ALSUntangled No. 8: Low dose naltrexone for ALS. - Suppr | 超能文献

ALSUntangled No. 8: Low dose naltrexone for ALS.

出版信息

Amyotroph Lateral Scler. 2011 Jan;12(1):76-8. doi: 10.3109/17482968.2010.544386. Epub 2010 Dec 21.

DOI:10.3109/17482968.2010.544386

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

ALSUntangled No. 8: Low dose naltrexone for ALS.

Amyotroph Lateral Scler. 2011 Jan;12(1):76-8. doi: 10.3109/17482968.2010.544386. Epub 2010 Dec 21.

2

Drug therapy in amyotrophic lateral sclerosis.肌萎缩侧索硬化症的药物治疗

Phys Med Rehabil Clin N Am. 2008 Aug;19(3):633-51, xi-xii. doi: 10.1016/j.pmr.2008.04.005.

3

Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS.肌萎缩侧索硬化症患者对高剂量（每日3000毫克）辅酶Q10的耐受性

Neurology. 2005 Dec 13;65(11):1834-6. doi: 10.1212/01.wnl.0000187070.35365.d7.

4

Commentary on 'a novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS'.关于“一项比较肌萎缩侧索硬化症药物治疗组合的新型、高效、随机选择试验”的评论

Amyotroph Lateral Scler. 2008 Aug;9(4):254-6. doi: 10.1080/17482960802192324.

5

Reversal of signs and symptoms of a B-cell lymphoma in a patient using only low-dose naltrexone.仅使用低剂量纳曲酮使一名患者的B细胞淋巴瘤体征和症状得到逆转。

Integr Cancer Ther. 2007 Sep;6(3):293-6. doi: 10.1177/1534735407306358.

6

[Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].[肌萎缩侧索硬化症（ALS）的神经保护治疗]

Rinsho Shinkeigaku. 1996 Dec;36(12):1329-30.

7

[Cotreatment of amyotrophic lateral sclerosis patients].[肌萎缩侧索硬化症患者的联合治疗]

Rinsho Shinkeigaku. 1999 Dec;39(12):1253-5.

8

Clinical and experimental neuroprotection in neurodegenerative diseases is a therapeutic option for the future of amyotrophic lateral sclerosis (ALS). Preface.神经退行性疾病的临床和实验性神经保护是肌萎缩侧索硬化症（ALS）未来的一种治疗选择。前言。

J Neurol. 2000 Dec;247 Suppl 6:VI/1. doi: 10.1007/BF03161073.

9

ALSUntangled No. 16: cannabis.肌萎缩侧索硬化症解读第16期：大麻

Amyotroph Lateral Scler. 2012 Jun;13(4):400-4. doi: 10.3109/17482968.2012.687264.

10

Toward more efficient clinical trials for amyotrophic lateral sclerosis.迈向更高效的肌萎缩侧索硬化症临床试验。

Amyotroph Lateral Scler. 2010 May 3;11(3):259-65. doi: 10.3109/17482960903358865.

引用本文的文献

1

Use of Off-Label Drugs and Nutrition Supplements among Patients with Amyotrophic Lateral Sclerosis in Norway.挪威肌萎缩侧索硬化症患者使用非标签药物和营养补充剂的情况。

Neurol Res Int. 2022 Apr 12;2022:1789946. doi: 10.1155/2022/1789946. eCollection 2022.

2

Mining online social network data for biomedical research: a comparison of clinicians' and patients' perceptions about amyotrophic lateral sclerosis treatments.挖掘在线社交网络数据用于生物医学研究：临床医生与患者对肌萎缩侧索硬化症治疗看法的比较

J Med Internet Res. 2012 Jun 21;14(3):e90. doi: 10.2196/jmir.2127.

3

Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm.利用在线自我报告的患者数据和患者匹配算法加速临床发现。

Nat Biotechnol. 2011 May;29(5):411-4. doi: 10.1038/nbt.1837. Epub 2011 Apr 24.